Cargando…
Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
Recently, scary viral pneumonia is known as (COVID-19) has swept the whole world. The new virus strain designated as SARS-CoV-2 belonging to the coronavirus family. Although the current medical research directed towards the development of a novel therapeutic agent, no anti-viral drug approved until...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399655/ https://www.ncbi.nlm.nih.gov/pubmed/32839634 http://dx.doi.org/10.1016/j.molliq.2020.113968 |